Key points: OCGN stock tanked 23% premarket on FDA disapproval of Covaxin EAU Once trading at $600, OCGN now can be snapped up for just above $3 After last weeks 50% s

Key points: LAIX stock price soared 1,115.9% after a 14 to 1 reverse stock split. The stock split only affected the American ADSs, not the Chinese shares. The move l

Key points: Rivian CEO backs out of pricing changes following public uproar /li> Pre-order pricing will be honoured, but changes to future orders will remain CEO outlines t

Key points: ITM Power shares have fallen 20.15% in 2022 but recently turned higher. Many argue that ITM shares are richly valued, which is entirely accurate. The hyd

Key points: Supply@ME Capital shares plunged 30% after its chairman resigned. However, the drastic move seems like an overreaction, raising questions. For example, wil

Key points: Chill Brands shares crashed 31% after it missed H2 revenue targets. The CBD company attributed the revenue miss to geopolitical events. However, the firm

Key points: Phoenix Global is a fracking play in the Vaca Muerta of Argentina We know there is oil there the question is how much can be extracted? Phoenix shares fell 16

Key points: Hammerson has announced annual results and the shares are fading Rental income and earnings are up but a large overall loss The portfolio is falling in value e

Key points: Pantheon Resources has suspended testing of the SMD horizon To translate, this means no sign yet of recoverable oil Attention is therefore moving to Theta West

Key points: A once hotly anticipated EV truck maker, things have taken a turn for the worse for RIDE Ex-CEO sells $13M of shares, followed by GM's total $75M stake Th

Key points: Morgan Stanley argue INTC stock is likely to move sideways for the coming years The market offers higher growth opportunities from rising tech INTC stock

Key points: Customers are left enfuriated after widespread pre-oder price hikes Preorder numbers might be dubious following customer cancellations Rivian amongst othe

Key points: Tonix Pharma shares soared 58.2% after being granted orphan drug designation. The biotech company is developing a treatment for Prader-Willi syndrome in adults.

Key points: Snowflake shares crashed 21.8% on weak FY23 revenue growth forecasts. Investors ignored the company’s upbeat Q4 revenues to focus on guidance. Like most

Key points: Popular retailer misses earnings expectations for popular Q4 holiday period BBY stock rallied as much as 10% in Thursday premarket trading following promising outlook

Key points: Kiromic Bio stock price rallied 38.8% despite the lack of announcements. The shares came under significant buying pressure to cross the $1 mark. However,

Key points: Natwest shares have fallen 11.3% in one month amid selling pressure. However, the bank’s fundamentals remain strong as operating condit

Key points: RBC has upgraded Biogen to outperfor This follows the 50% stock price fall following the Aduhelm saga Is this from RBC just about the current price?

Key points: Darktrace shares surged 19.7% on upbeat six months results. The company finally cut ties with Mike Lynch, and its business is gaining. Moreover, there se

Key points: Morses Club Announces its perfectly decent doorstep lending business An increase in business, profits being made, what’s the problem? But is Morses Club going